RT Journal Article
SR Electronic
T1 Risk factors for severe complications and mortality among hospitalized children with measles during a major outbreak in Northern Vietnam, 2017 - 2019
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.16.23292745
DO 10.1101/2023.07.16.23292745
A1 Tran, Minh Dien
A1 Pham, Nhung T. H.
A1 Vu, Hoang Nguyen
A1 Tran, Minh-Hung
A1 Ngo, Hoang-Anh
A1 Phan, Phuc H
YR 2024
UL http://medrxiv.org/content/early/2024/01/18/2023.07.16.23292745.abstract
AB Introduction Measles outbreaks increased worldwide during the period of 2017-2019. Similarly, Vietnam experienced one of the largest measles outbreaks in recent decades, with various paediatric patients presenting severe complications. In this study, we aim to identify factors associated with death and severity among children with measles admitted to Vietnam National Children’s Hospital (VNCH) in Hanoi, Vietnam between 2017 and 2019.Method This single-center retrospective cohort study included 2, 072 patients with measles admitted to VNCH from 1/1/2017 to 31/12/2019. Data on epidemiological, clinical characteristics, vaccine status, and outcomes were collected and summarised. We conducted both univariable and multivariable logistic regression analyses to examine the correlations between various characteristics of hospitalized children and mortality.Findings In total, there were 2, 072 patients, including 1, 297 (62.6%) males and 775 (37.4%) females. The median age was 9 months (interquartile range 7 − 17). 87.3% of cases had not received any measles-containing vaccine (MCV). 30 (1.4%) patients died, with 40% aged less than 9 months. Only 3 among 30 (10%) who died had received at least 1 dose of MCV. Bronchopneumonia was the most common complication, occurring in 1, 413 (68.2%) patients. The following characteristics were significantly associated with mortality in the multivariable analysis: age under 9 months and age from 9 months to 5 years, residing 20 to 200 kilometres from VNCH, and having co-infection with adenovirus or other hospital acquired infections. Age group was also significantly associated with severity in the multivariable analysis.Interpretation Vietnam continues to face the threat of future measles epidemics, given the burden of hospitalization and the high rate of complications observed in hospitalized patients. This highlights the critical need to maintain high measles vaccine coverage, particularly by targeting the unvaccinated population. To prevent future outbreaks and lower measles incidence, routine immunization needs to be strengthened, and earlier scheduling of MCV1 needs to be further evaluated. The comprehensive analysis of the 2017-19 measles outbreak presented in this study will contribute to informed decision-making regarding appropriate measures to counteract future resurgences of measles in Vietnam.Funding No specific grant from funding agencies in the public, commercial or not-for-profit sectors supported the submission and publication of this manuscript.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo specific grant from funding agencies in the public, commercial or not-for-profit sectors supported the submission and publication of this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Ethics Committee in Biomedical Research, Vietnam National Children's Hospital (Ref:473/BVNTW-HDDD, IRB identifier: IRB - VN01037/IRB00011976/FWA00028418). As the study involved a retrospective analysis of routinely collected data under strict anonymity, patient or caregiver consent was not required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.